Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  The Journal of the National Comprehensive Cancer Network

• Publication date

  2013-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.6004/JNCCN.2013.0087PMID 23744867PMCID PMC4530628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence of Childhood and Adolescent Melanoma in the United States: 1973–2009

  2013cited by this paper
• Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors.

  2013cited by this paper
• Guidelines of care for the management of primary cutaneous melanoma.

  2013cited by this paper
• Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study

  2013cited by this paper
• The Unique Clinical Characteristics of Melanoma Diagnosed in Children

  2012cited by this paper
• Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma

  2012cited by this paper
• Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline.

  2012cited by this paper
• Unanswered questions about margin recommendations for primary cutaneous melanoma.

  2012cited by this paper
• Outcomes in Pediatric Atypical Spitz Tumors Treated Without Sentinel Lymph Node Biopsy

  2012cited by this paper
• Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.

  2012cited by this paper
• Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study

  2012cited by this paper
• Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.

  2012cited by this paper
• Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline

  2012cited by this paper
• Agreement of Dermatopathologists in the Evaluation of Clinically Difficult Melanocytic Lesions: How Golden Is the ‘Gold Standard’?

  2012cited by this paper
• Excised melanocytic lesions in children and adolescents – a 10‐year survey

  2012cited by this paper
• Sentinel node biopsy in atypical melanocytic neoplasms in childhood: a single institution experience in 24 patients

  2012cited by this paper
• Melanoma in children.

  2011cited by this paper
• Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children.

  2011cited by this paper
• p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.

  2011cited by this paper
• Spitz nevi, atypical spitzoid neoplasms, and spitzoid melanoma.

  2011cited by this paper
• Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology.

  2011cited by this paper
• Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

  2011cited by this paper
• Update on fluorescence in situ hybridization in melanoma: state of the art.

  2011cited by this paper
• MMPs are regulatory enzymes in pathways of inflammatory disorders, tissue injury, malignancies and remodelling of the lung

  2011cited by this paper
• Faculty of 1000 evaluation for Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children.

  2011cited by this paper
• Use of Anti-phosphohistone H3 Immunohistochemistry to Determine Mitotic Rate in Thin Melanoma

  2010cited by this paper
• FISH analysis for diagnostic evaluation of challenging melanocytic lesions.

  2010cited by this paper
• Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair

  2010cited by this paper
• Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis.

  2010cited by this paper
• Improved survival with ipilimumab in patients with metastatic melanoma.

  2010cited by this paper
• Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.

  2010cited by this paper
• The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I)

  2010cited by this paper
• Melanocytic Tumors of Uncertain Malignant Potential: Results of a Tutorial Held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008

  2010cited by this paper
• Melanoma and Melanocytic Tumors of Uncertain Malignant Potential in Children, Adolescents and Young Adults—The Stanford Experience 1995–2008

  2010cited by this paper
• Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

  2010cited by this paper
• The Atypical Spitz Tumor of Uncertain Biologic Potential: A Series of 67 Patients From a Single Institution

  2010cited by this paper
• Comparative genomic hybridization for the diagnosis of melanoma

  2009cited by this paper
• Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?

  2009cited by this paper
• Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

  2009cited by this paper
• Diagnosis of cutaneous melanocytic tumours by four‐colour fluorescence in situ hybridisation

  2009cited by this paper
• Pediatric melanoma: a review.

  2009cited by this paper
• Spitz Nevi, Atypical Spitzoid Neoplasms, and Spitzoid Melanoma.

  2009cited by this paper
• Pediatric melanoma: a single-institution experience of 150 patients.

  2009cited by this paper
• The atypical Spitz tumor of uncertain biologic potential

  2009cited by this paper
• Sentinel Lymph Node Biopsy in Pediatric and Adolescent Cutaneous Melanoma Patients

  2009cited by this paper
• Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

  2008cited by this paper
• Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions

  2008cited by this paper
• Trends in Pediatric Melanoma Mortality in the United States, 1968 through 2004

  2007cited by this paper
• Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base.

  2007cited by this paper
• PET CT imaging in patients undergoing sentinel node biopsy for melanoma.

  2007cited by this paper
• Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study

  2006cited by this paper
• Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis

  2005cited by this paper
• The feasibility of adjuvant interferon α‐2b in children with high‐risk melanoma

  2005cited by this paper
• High‐risk surgically resected pediatric melanoma and adjuvant interferon therapy

  2005cited by this paper
• The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma.

  2005cited by this paper
• Does Melanoma Behave Differently in Younger Children Than in Adults? A Retrospective Study of 33 Cases of Childhood Melanoma From a Single Institution

  2005cited by this paper
• Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents.

  2005cited by this paper
• Use of Bayes rule and MIB-1 proliferation index to discriminate Spitz nevus from malignant melanoma.

  2004cited by this paper
• High-Resolution Array-Based Comparative Genomic Hybridization for Distinguishing Paraffin-Embedded Spitz Nevi and Melanomas

  2004cited by this paper
• A Pooled Analysis of Eastern Cooperative Oncology Group and Intergroup Trials of Adjuvant High-Dose Interferon for Melanoma

  2004cited by this paper
• The approach to the patient with a difficult melanocytic lesion.

  2004cited by this paper
• Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma

  2004cited by this paper
• Classifying melanocytic tumors based on DNA copy number changes.

  2003cited by this paper
• Value of ultrasonography compared with physical examination for the detection of locoregional metastases in patients with cutaneous melanoma

  2003cited by this paper
• High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.

  2001cited by this paper
• High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696.

  2001cited by this paper
• Pediatric Melanoma: Are Recent Advances in the Management of Adult Melanoma Relevant to the Pediatric Population

  2000cited by this paper
• High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

  2000cited by this paper
• Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.

  1999cited by this paper
• Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

  1996cited by this paper
• Melanoma in children.

  1995cited by this paper
• Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations.

  1992cited by this paper
• Metastatic malignant melanoma in prepubertal children.

  1975cited by this paper

• Review of Non-Invasive Imaging Technologies for Cutaneous Melanoma

  2025cites this paper
• Melanoma in Special Populations: Pediatrics, Elders, Pregnant Women.

  2025cites this paper
• Clinical and histopathological characteristics of melanomas in Asians under age 40

  2025cites this paper
• Temporal trends and unbalanced distribution, in pediatric cutaneous melanoma in 204 countries and territories, 1990-2019

  2025cites this paper
• Melanoma in Pediatric and Young Adult Patients

  2024cites this paper
• A Physician's Guide to the Use of Gene Expression Profile Ancillary Diagnostic Testing for Cutaneous Melanocytic Neoplasms.

  2023cites this paper
• Melanoma

  2020cites this paper
• Nonmelanoma Skin Cancer and Cutaneous Melanoma in the Pediatric Population

  2020cites this paper
• Classification and Histopathology of Melanoma

  2019cites this paper
• Melanoma cutáneo: algunas consideraciones actuales

  2019cites this paper
• Principles for Melanoma Diagnosis Learned From the Study of Nevi in Children (SONIC)

  2018cites this paper
• Pediatric melanoma and aggressive Spitz tumors: a retrospective diagnostic, exposure and outcome analysis.

  2018cites this paper
• Genomic analysis and clinical management of adolescent cutaneous melanoma

  2017cites this paper
• Chapter 2 Next Generation Sequencing in Aquatic Models

  2017cites this paper
• Expression von Cancer-Testis(CT)-Antigenen in Melanomen des Kindes- und Jugendalters

  2017influential citation
• [Expression of cancer testis (CT) antigens in pediatric and adolescent melanomas].

  2017cites this paper
• Melanocytic nevi and non-neoplastic hyperpigmentations.

  2017cites this paper
• The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing

  2016cites this paper
• [Update on surgical treatment of primary and metastatic cutaneous melanoma].

  2016cites this paper
• Pediatric Melanoma and Atypical Melanocytic Neoplasms.

  2016cites this paper
• Pediatric melanoma.

  2016cites this paper
• Update on surgical treatment of primary and metastatic cutaneous melanoma

  2016cites this paper
• Next Generation Sequencing in Aquatic Models

  2016cites this paper
• Actualización en el tratamiento quirúrgico del melanoma cutáneo primario y metastásico

  2016cites this paper
• Treating melanoma in adolescents and young adults: challenges and solutions

  2015cites this paper
• TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms

  2015cites this paper
• Spitzoid melanoma of childhood: a case series and review.

  2015cites this paper
• Malignant soft tissue lesions

  2015cites this paper
• Sentinel Lymph Node Biopsy in Melanoma and Other Cutaneous Malignancies | PER

  2014cites this paper
• Surgical management of melanoma.

  2014cites this paper
• Workup and staging of malignant melanoma.

  2014cites this paper
• Unusual presentations of melanoma: melanoma of unknown primary site, melanoma arising in childhood, and melanoma arising in the eye and on mucosal surfaces.

  2014cites this paper
• Update on pediatric dermatologic surgery from tots to teens

  2014cites this paper
• Fluorescence In Situ Hybridization Analysis of Atypical Melanocytic Proliferations and Melanoma in Young Patients

  2014cites this paper
• Sentinel Lymph Node Biopsy in Melanoma and Other Cutaneous Malignancies

  2014cites this paper
• Pediatric melanoma: the whole (genome) story.

  2014cites this paper